These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10480398)

  • 1. Mixed chimerism as an approach for the induction of transplantation tolerance.
    Wekerle T; Sykes M
    Transplantation; 1999 Aug; 68(4):459-67. PubMed ID: 10480398
    [No Abstract]   [Full Text] [Related]  

  • 2. Transplantation tolerance and mixed chimerism: at the frontier of clinical application.
    Donckier V; Toungouz M; Goldman M
    Transpl Int; 2001; 14(1):1-5. PubMed ID: 11263549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed allogeneic chimerism as a reliable model for composite tissue allograft tolerance induction across major and minor histocompatibility barriers.
    Foster RD; Ascher NL; McCalmont TH; Neipp M; Anthony JP; Mathes SJ
    Transplantation; 2001 Sep; 72(5):791-7. PubMed ID: 11571439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed allogeneic chimerism. Past, present, and prospects for the future.
    Brouha PC; Ildstad ST
    Transplantation; 2001 Oct; 72(8 Suppl):S36-42. PubMed ID: 11888155
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaching tolerance in transplantation.
    Waldmann H; Cobbold S
    Int Arch Allergy Immunol; 2001 Sep; 126(1):11-22. PubMed ID: 11641602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimerism after organ transplantation.
    Starzl TE; Demetris AJ; Murase N; Trucco M; Thomson AW; Rao AS; Fung JJ
    Curr Opin Nephrol Hypertens; 1997 May; 6(3):292-8. PubMed ID: 9263673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
    Tomita Y; Sachs DH; Khan A; Sykes M
    Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell migration and chimerism--a unifying concept in transplantation--with particular reference to HLA matching and tolerance induction.
    Starzl TE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):8-12. PubMed ID: 8438487
    [No Abstract]   [Full Text] [Related]  

  • 11. Roles of deletion and regulation in creating mixed chimerism and allograft tolerance using a nonlymphoablative irradiation-free protocol.
    Domenig C; Sanchez-Fueyo A; Kurtz J; Alexopoulos SP; Mariat C; Sykes M; Strom TB; Zheng XX
    J Immunol; 2005 Jul; 175(1):51-60. PubMed ID: 15972631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed allogeneic chimerism as an approach to transplantation tolerance.
    Sykes M; Sachs DH
    Immunol Today; 1988 Jan; 9(1):23-7. PubMed ID: 3076756
    [No Abstract]   [Full Text] [Related]  

  • 13. New approaches to transplantation tolerance.
    Smith CV; Rosengard BR; Guzzetta PC; Nakajima K; Sachs DH
    Transplant Proc; 1991 Aug; 23(4):2157-61. PubMed ID: 1871834
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimerism and central tolerance.
    Sykes M
    Curr Opin Immunol; 1996 Oct; 8(5):694-703. PubMed ID: 8902396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy.
    Forman D; Tian C; Iacomini J
    Mol Ther; 2005 Aug; 12(2):353-9. PubMed ID: 15939670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model.
    Huang CA; Fuchimoto Y; Scheier-Dolberg R; Murphy MC; Neville DM; Sachs DH
    J Clin Invest; 2000 Jan; 105(2):173-81. PubMed ID: 10642595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current progress in chimerism and donor-specific tolerance.
    Jankowski RA; Ildstad ST
    Transplant Proc; 1996 Aug; 28(4):2071-4. PubMed ID: 8769159
    [No Abstract]   [Full Text] [Related]  

  • 19. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts.
    Exner BG; Acholonu IN; Bergheim M; Mueller YM; Ildstad ST
    Acta Haematol; 1999; 101(2):78-81. PubMed ID: 10202237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.